Form 4 for UPXI UPEXI, INC.
Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-17 · accession 0001477932-25-008466 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-11-18 | 2025-11-17 | UPXI | Salkind Gene | Dir | P - Purchase | $2.81 | +100.0K | 168.8K | +145% | +$281.0K |
| 2025-11-18 | 2025-11-17 | UPXI | Salkind Gene | Dir | P - Purchase | $2.65 | +100.0K | 569.5K | +21% | +$265.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-17 | P | A | 100,000 | $2.81 | 168,750 | I | — | — | (F1) 100,000 shares were purchased at $2.81 per share on the open market through the Marital Trust GST subject U/W/O Leopold Salkind Gene Salkind, Trustee. These shares are considered indirect ownership of Gene Salkind. |
| 2 | Common | Common Stock | 2025-11-17 | P | A | 100,000 | $2.65 | 569,470 | D Trustee | — | — |